Crescita Therapeutics Inc.
CTX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.45M | 6.25M | 6.58M | 7.04M | 7.11M |
| Total Receivables | 1.19M | 941.60K | 1.68M | 2.59M | 2.10M |
| Inventory | 2.82M | 4.54M | 3.85M | 3.74M | 4.64M |
| Prepaid Expenses | 181.40K | -- | -- | -- | 150.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 329.40K | 331.70K | 199.40K | -- |
| Total Current Assets | 10.64M | 12.05M | 12.45M | 13.57M | 14.00M |
|
|
|||||
| Total Current Assets | 10.64M | 12.05M | 12.45M | 13.57M | 14.00M |
| Net Property, Plant & Equipment | 1.68M | 1.68M | 1.21M | 1.24M | 1.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.21M | 1.39M | 1.49M | 1.31M | 1.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.39M | 1.40M | 1.37M | 1.40M | 1.45M |
| Total Assets | 15.13M | 16.79M | 16.77M | 17.77M | 18.63M |
|
|
|||||
| Total Accounts Payable | 3.47M | 4.10M | 3.33M | 3.42M | 3.28M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 326.00K | 335.30K | 327.30K | 327.90K | 332.40K |
| Total Finance Division Other Current Liabilities | 34.80K | 37.00K | 36.50K | 36.90K | 75.70K |
| Total Other Current Liabilities | 34.80K | 37.00K | 36.50K | 36.90K | 75.70K |
| Total Current Liabilities | 3.83M | 4.47M | 3.70M | 3.78M | 3.68M |
|
|
|||||
| Total Current Liabilities | 3.83M | 4.47M | 3.70M | 3.78M | 3.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 253.70K | 350.10K | 429.60K | 518.40K | 617.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 46.60K | 82.90K | 78.20K | 75.30K | 73.50K |
| Total Liabilities | 4.13M | 4.90M | 4.21M | 4.38M | 4.37M |
|
|
|||||
| Common Stock & APIC | 41.75M | 44.51M | 44.00M | 44.49M | 45.66M |
| Retained Earnings | -31.52M | -33.45M | -32.26M | -31.92M | -32.26M |
| Treasury Stock & Other | 770.80K | 829.00K | 819.80K | 828.60K | 851.10K |
| Total Common Equity | 11.00M | 11.89M | 12.56M | 13.40M | 14.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.00M | 11.89M | 12.56M | 13.40M | 14.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.00M | 11.89M | 12.56M | 13.40M | 14.25M |
|
|
|||||